• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性去甲肾上腺素通过紧密的激动剂结合掩盖大鼠心脏膜中的β-肾上腺素能受体。

Endogenous noradrenaline masks beta-adrenergic receptors in rat heart membranes via tight agonist binding.

作者信息

Nerme V, Severne Y, Abrahamsson T, Vauquelin G

出版信息

Biochem Pharmacol. 1985 Aug 15;34(16):2917-22. doi: 10.1016/0006-2952(85)90016-4.

DOI:10.1016/0006-2952(85)90016-4
PMID:2862872
Abstract

The tight binding of noradrenaline (NA) to beta-adrenergic receptors was studied in membranes from the left ventricular myocardium of the rat. Addition of GTP (0.1 mM) to membrane preparations from control rats (NA concentration 8.5 +/- 2.1 nM) caused a 4-35% (N = 8) increase (P less than 0.01) in the number of specific binding sites of 125Ipindolol. In contrast, addition of GTP did not cause any changes in the number of beta-adrenergic receptors in heart membranes from reserpinized animals (NA concentration less than 0.1 nM). In heart membranes from reserpinized animals, preincubation with NA (followed by washing) revealed a time- and concentration-dependent decrease with a maximum of 35-40% in the 125Ipindolol-binding sites. This agonist-mediated decrease in the number of receptors was prevented if GTP was also present in the NA-preincubation medium. It is concluded that NA can undergo tight binding to beta-adrenergic receptors in rat heart membranes. The heart-membrane preparations contain endogenous NA which, via tight agonist binding, is responsible for masking part of the beta-adrenergic receptor population.

摘要

研究了去甲肾上腺素(NA)与大鼠左心室心肌膜中β-肾上腺素能受体的紧密结合情况。向对照大鼠的膜制剂(NA浓度8.5±2.1 nM)中添加GTP(0.1 mM),导致[125I]-吲哚洛尔特异性结合位点数量增加4 - 35%(N = 8)(P < 0.01)。相比之下,向利血平化动物的心脏膜中添加GTP,并未引起β-肾上腺素能受体数量的任何变化(NA浓度< 0.1 nM)。在利血平化动物的心脏膜中,用NA预孵育(随后洗涤)显示[125I]-吲哚洛尔结合位点呈时间和浓度依赖性减少,最大减少35 - 40%。如果在NA预孵育培养基中也存在GTP,则可防止这种激动剂介导的受体数量减少。结论是,NA可与大鼠心脏膜中的β-肾上腺素能受体发生紧密结合。心脏膜制剂中含有内源性NA,其通过紧密的激动剂结合,导致部分β-肾上腺素能受体群体被掩盖。

相似文献

1
Endogenous noradrenaline masks beta-adrenergic receptors in rat heart membranes via tight agonist binding.内源性去甲肾上腺素通过紧密的激动剂结合掩盖大鼠心脏膜中的β-肾上腺素能受体。
Biochem Pharmacol. 1985 Aug 15;34(16):2917-22. doi: 10.1016/0006-2952(85)90016-4.
2
Spontaneous coupling of the beta-adrenergic receptor to Ns in mammalian cardiac membranes.哺乳动物心脏膜中β-肾上腺素能受体与Ns的自发偶联。
Mol Pharmacol. 1986 Jul;30(1):1-5.
3
Genetic influences on agonist binding to cardiac beta-receptors.基因对激动剂与心脏β受体结合的影响。
Biochem Pharmacol. 1988 Apr 1;37(7):1281-6. doi: 10.1016/0006-2952(88)90783-6.
4
Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.心肌膜制剂中125I-碘氰吲哚洛尔的特异性非β-肾上腺素能结合位点:人、大鼠和猪心脏的比较研究。
Cardiovasc Res. 1991 Sep;25(9):764-73. doi: 10.1093/cvr/25.9.764.
5
Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.非典型激动剂对β-1和β-2肾上腺素能受体的选择性调节。
J Pharmacol Exp Ther. 1985 Dec;235(3):657-64.
6
Homogeneous class of beta-1 adrenergic receptors in rat kidney. Identification by (+/-)-125 iodocyanopindolol binding.大鼠肾脏中β-1肾上腺素能受体的同质性类别。通过(±)-125碘氰吲哚洛尔结合进行鉴定。
Biochem Pharmacol. 1982 May 1;31(9):1743-7. doi: 10.1016/0006-2952(82)90678-5.
7
Shallow agonist competition binding curves for beta-adrenergic receptors: the role of tight agonist binding.
Mol Pharmacol. 1987 Jan;31(1):69-73.
8
Biphasic binding of 125I-iodocyanopindolol to beta-adrenergic receptors in rat cerebral cortical membranes. I. Assessment by the use of agonists.125I-碘氰吲哚洛尔与大鼠大脑皮质膜中β-肾上腺素能受体的双相结合。I. 使用激动剂进行评估。
Chem Pharm Bull (Tokyo). 1987 Jul;35(7):2966-72. doi: 10.1248/cpb.35.2966.
9
Interactions of agonists and antagonists with beta-adrenergic receptors on intact L6 muscle cells.激动剂和拮抗剂与完整L6肌细胞上β-肾上腺素能受体的相互作用。
J Cyclic Nucleotide Res. 1980;6(6):421-35.
10
Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.棕色脂肪组织和骨骼肌膜中假定的β3-肾上腺素能受体的配体结合特性比较
Br J Pharmacol. 1993 Aug;109(4):1157-63. doi: 10.1111/j.1476-5381.1993.tb13743.x.

引用本文的文献

1
Chronic (-)-isoprenaline infusion down-regulates beta 1- and beta 2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart.慢性输注(-)-异丙肾上腺素可下调大鼠心脏中的β1和β2肾上腺素能受体,但不会对毒蕈碱胆碱能受体进行转调节。
Naunyn Schmiedebergs Arch Pharmacol. 1996 Jan;353(2):213-25. doi: 10.1007/BF00168760.
2
Beta-adrenoceptor regulation and functional responses in the guinea-pig following chronic administration of the long-acting beta 2-adrenoceptor agonist formoterol.长期给予长效β2肾上腺素能激动剂福莫特罗后豚鼠体内β肾上腺素能受体的调节及功能反应
Naunyn Schmiedebergs Arch Pharmacol. 1995 Jun;351(6):576-88. doi: 10.1007/BF00170156.
3
Independent regulation of beta 1- and beta 2-adrenoceptors.
β1和β2肾上腺素能受体的独立调节
Br J Pharmacol. 1987 Dec;92(4):827-34. doi: 10.1111/j.1476-5381.1987.tb11387.x.
4
Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.具有部分激动活性的β-肾上腺素受体拮抗剂(非选择性以及β1选择性)可降低人淋巴细胞中的β2-肾上腺素受体密度。部分激动活性中β2激动成分的证据。
Naunyn Schmiedebergs Arch Pharmacol. 1986 Jun;333(2):130-8. doi: 10.1007/BF00506515.
5
(+)-sotalol causes significant occupation of beta-adrenoceptors at concentrations that prolong cardiac repolarization.
Naunyn Schmiedebergs Arch Pharmacol. 1990 Mar;341(3):215-20. doi: 10.1007/BF00169733.
6
Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation.Xamoterol与异丙肾上腺素对大鼠心脏β-肾上腺素能受体作用的比较:功能与调节研究
Br J Pharmacol. 1990 Jan;99(1):27-30. doi: 10.1111/j.1476-5381.1990.tb14648.x.
7
The beta 1- and beta 2-adrenoceptor affinity and beta 1-blocking potency of S- and R-metoprolol.S-美托洛尔和R-美托洛尔的β1及β2肾上腺素能受体亲和力与β1阻断效能
Br J Pharmacol. 1990 Mar;99(3):592-6. doi: 10.1111/j.1476-5381.1990.tb12974.x.